Targeting MicroRNAs With Small Molecules: From Dream to Reality

Currently, one out of four deaths in the United States is due to cancer; therefore, every major therapeutic advance in cancer has the potential to save many lives. One of the most fascinating discoveries in the area of molecular oncology in the past decade is that, in cancer, alterations in both protein‐coding genes and noncoding RNAs, known as microRNAs (miRNAs), complement each other. In this article, we focus on a novel idea involving the use of small molecules to target overexpressed miRNAs as a new therapy for diseases, particularly cancer, in humans.

[1]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[2]  R. Breaker,et al.  Riboswitches as antibacterial drug targets , 2006, Nature Biotechnology.

[3]  Qihong Huang,et al.  Small-molecule inhibitors of microrna miR-21 function. , 2008, Angewandte Chemie.

[4]  Jennifer A. Doudna,et al.  Structural insights into RNA Processing by the Human RISC-Loading Complex , 2009, Nature Structural &Molecular Biology.

[5]  I. Kuntz,et al.  DOCK 6: combining techniques to model RNA-small molecule complexes. , 2009, RNA.

[6]  Holger Gohlke,et al.  DrugScoreRNAKnowledge-Based Scoring Function To Predict RNA-Ligand Interactions , 2007, J. Chem. Inf. Model..

[7]  Andrea Califano,et al.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.

[8]  S. David Morley,et al.  Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock® , 2004, J. Comput. Aided Mol. Des..

[9]  D. Baker,et al.  Automated de novo prediction of native-like RNA tertiary structures , 2007, Proceedings of the National Academy of Sciences.

[10]  Paul J Hergenrother,et al.  Targeting RNA with small molecules. , 2008, Chemical reviews.

[11]  C. Croce,et al.  MiR-15a and miR-16-1 cluster functions in human leukemia , 2008, Proceedings of the National Academy of Sciences.

[12]  Wojciech Kasprzak,et al.  Bridging the gap in RNA structure prediction. , 2007, Current opinion in structural biology.

[13]  F. Major,et al.  The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data , 2008, Nature.

[14]  George A. Calin,et al.  Mammalian microRNAs: a small world for fine-tuning gene expression , 2006, Mammalian Genome.

[15]  Stefano Volinia,et al.  Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[17]  Z. Paroo,et al.  A small molecule enhances RNA interference and promotes microRNA processing , 2008, Nature Biotechnology.

[18]  Gabriele Varani,et al.  Validation of automated docking programs for docking and database screening against RNA drug targets. , 2004, Journal of medicinal chemistry.

[19]  R. Spizzo,et al.  RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. , 2009, Clinical lymphoma & myeloma.

[20]  D. Goodsell,et al.  Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock , 2002, Proteins.

[21]  Stephen Hanessian,et al.  Docking of aminoglycosides to hydrated and flexible RNA. , 2006, Journal of medicinal chemistry.

[22]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[23]  Shangqin Guo,et al.  MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. , 2008, Developmental cell.

[24]  V. Ambros,et al.  The evolution of our thinking about microRNAs , 2008, Nature Medicine.

[25]  Jie Shen,et al.  Accuracy Assessment of Protein-Based Docking Programs against RNA Targets , 2010, J. Chem. Inf. Model..

[26]  R. Place,et al.  MicroRNA-373 induces expression of genes with complementary promoter sequences , 2008, Proceedings of the National Academy of Sciences.

[27]  Nicolas Foloppe,et al.  Towards the discovery of drug-like RNA ligands? , 2006, Drug discovery today.

[28]  Zhihua Du,et al.  Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA. , 2002, Chemistry & biology.

[29]  George A Calin,et al.  microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. , 2010, Blood.

[30]  V. Ambros,et al.  The regulation of genes and genomes by small RNAs , 2007, Development.

[31]  M. Caligiuri,et al.  miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts , 2010, Cell.

[32]  C. Croce,et al.  Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. , 2009, Blood.

[33]  Mariette Schrier,et al.  A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.